Polycystic Ovary Syndrome: A Complex Interplay of Hormones and Metabolism

Abstract

Context: Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting women of reproductive age, characterized by hormonal imbalances and metabolic disturbances. The condition manifests through ovulatory dysfunction, hyperandrogenism, and polycystic ovarian morphology. Symptoms frequently emerge during puberty, often overlapping with normal developmental changes, creating diagnostic challenges. Early identification using standardized criteria is crucial for effective management and prevention of long-term complications. Evidence Acquisition: A comprehensive literature search was conducted across PubMed, CINAHL, and PsycINFO databases using controlled vocabulary and keywords, including "polycystic ovary syndrome", "PCOS diagnosis", "insulin resistance", and "metabolic dysfunction". The search encompassed peer-reviewed studies published between 2000 - 2024, prioritizing recent evidence while including seminal older publications for historical context. Results: Polycystic ovary syndrome develops through an interplay of genetic predisposition and environmental factors, with insulin resistance serving as a central pathogenic mechanism. This metabolic disturbance elevates risks for type 2 diabetes, dyslipidemia, and cardiovascular disease (CVD), while hyperandrogenism drives symptoms including hirsutism, acne, and androgenetic alopecia. Diagnosis primarily utilizes the Rotterdam criteria, requiring at least two of three key features. Conclusions: Optimal management combines lifestyle interventions with targeted pharmacotherapy, including hormonal contraceptives, anti-androgens, and insulin-sensitizing agents. Emerging therapies such as inositol supplementation show promise. Future research should focus on refining diagnostic criteria and developing phenotype-specific management approaches to address this complex disorder's multifaceted manifestations.